[Substantiation of enterosane application for the treatment of celiac disease].
Bogdarin
Iu A
IuA
Repin
A A
AA
D000293:Adolescent; D000328:Adult; D000368:Aged; D002446:Celiac Disease / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004334:Drug Administration Schedule; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000473:pathology; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D005765:Gastrointestinal Agents